Working… Menu

Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02030184
Recruitment Status : Withdrawn (PI has left the study institution.)
First Posted : January 8, 2014
Last Update Posted : October 17, 2019
Information provided by (Responsible Party):
University of Maryland, Baltimore

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2021